Global Blood Therapeutics/Pfizer
Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. GBT’s goal is to advance the care and treatment of people with SCD through science, innovative medicines and access to solutions.